Royalty Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	938.94	929.03	477.01	1,711	1,541	1,009
Short-Term Investments	16.1	58.2	18.3	25.72	647.87	1,053
Cash & Short-Term Investments	955.04	987.23	495.31	1,736	2,189	2,062
Cash Growth	-4.36%	99.31%	-71.48%	-20.67%	6.16%	505.29%
Accounts Receivable	888.97	810.73	760.84	727.92	682.66	626.36
Receivables	888.97	810.73	760.84	727.92	682.66	626.36
Other Current Assets	5.52	4.19	18.04	90.52	6.63	8.6
Total Current Assets	1,850	1,802	1,274	2,555	2,878	2,697
Long-Term Investments	722.85	1,260	1,012	735.82	909.59	916.64
Other Intangible Assets	5.32	5.32	1.78	14.5	5.67	28.67
Long-Term Accounts Receivable	15,764	15,127	14,089	13,493	13,718	12,368
Other Long-Term Assets	61.46	28.21	4.74	15.13	4.14	10
Total Assets	19,347	18,223	16,382	16,813	17,516	16,020
Accounts Payable	41.42	13.37	15.17	7.91	5.62	10.78
Accrued Expenses	29.04	98.06	51.68	54.16	57.7	60.75
Current Portion of Long-Term Debt	380	997.77	-	997.51	-	-
Other Current Liabilities	77.22	144.41	94.53	107.2	107.93	236.37
Total Current Liabilities	530.8	1,254	161.38	1,167	171.25	307.89
Long-Term Debt	8,566	6,615	6,135	6,119	7,096	5,817
Other Long-Term Liabilities	612.98	12.08	0.9	2.5	-	-
Total Liabilities	9,726	7,880	6,298	7,288	7,267	6,124
Common Stock	0.11	0.11	0.11	0.11	0.11	0.1
Additional Paid-In Capital	4,113	4,103	4,011	3,666	3,508	2,866
Retained Earnings	2,304	2,846	2,518	1,965	2,255	1,921
Treasury Stock	-2.61	-2.66	-2.63	-2.81	-2.72	-2.32
Comprehensive Income & Other	-	-	-	-	16.49	34.4
Total Common Equity	6,414	6,947	6,526	5,628	5,777	4,819
Minority Interest	3,207	3,396	3,558	3,897	4,472	5,077
Shareholders' Equity	9,621	10,342	10,084	9,525	10,249	9,896
Total Liabilities & Equity	19,347	18,223	16,382	16,813	17,516	16,020
Total Debt	8,966	7,612	6,135	7,116	7,096	5,817
Net Cash (Debt)	-8,011	-6,625	-5,640	-5,380	-4,907	-3,755
Net Cash Per Share	-13.99	-11.15	-9.35	-12.28	-11.83	-10.00
Filing Date Shares Outstanding	427.25	433.32	446.69	443.17	432.96	388.13
Total Common Shares Outstanding	429.03	445.99	446.69	443.17	432.96	388.14
Working Capital	1,319	548.52	1,113	1,388	2,707	2,389
Book Value Per Share	14.95	15.58	14.61	12.70	13.34	12.42
Tangible Book Value	5,484	6,941	6,525	5,614	5,771	4,790
Tangible Book Value Per Share	12.78	15.56	14.61	12.67	13.33	12.34

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q